CXCL8 and ovarian cancer: In both discovery and validation sets, a four-biomarker panel of osteopontin, macrophage migration inhibitory factor, IL-8 AAb and CA125 exhibited greater sensitivity than CA125 alone in detecting early stage ovarian cancer.